Pharmacokinetic study of β-methyldigoxin by enzyme immunoassay using a novel specific antiserum in rats

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 2, 2003, Pages 247-251

  Higashi, Yasuhiko ^a   Watanabe, Naomi ^a   Sasaki, Toshiyuki ^a   Fujii, Youichi ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

methyldigoxin; Anti methyldigoxin 3 hemisuccinate bovine serum albumin antiserum; Commercial anti digoxin antiserum; Enzyme immunoassay; Pharmacokinetic study; Phenyl boric acid column

Indexed keywords

ANTISERUM; METILDIGOXIN;

ABSORPTION; ACCURACY; ARTICLE; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MONITORING; ENZYME IMMUNOASSAY; NONHUMAN; RAT; ANIMAL; COMPARATIVE STUDY; MALE; METHODOLOGY; WISTAR RAT;

ANIMALS; IMMUNE SERA; IMMUNOENZYME TECHNIQUES; MALE; MEDIGOXIN; RATS; RATS, WISTAR;

EID: 0042266882     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.26.247     Document Type: Article

References (21)

1. Valdes R., Jr., Brown B. A., Graves S. W., Am. J. Clin. Pathol., 82, 210-213 (1984).
2. Wahyono D., Piechaczyk M., Mourton C., Bastide J. M., Pau B., Hybridoma, 9, 619-629 (1990).
3. Miller J. J., Straub R. W., Jr., Valdes R., Jr., Clin. Chem., 40, 1898-1903 (1994).
4. Gault M. H., Longerich L. L., Loo J. C. K., Ko P. T. H., Fine A., Vasdev S. C., Dawe M. A., Clin. Pharmacol. Ther., 35, 74-82 (1984).
5. Hinderling P. H., Garrett E. R., Wester R. C., J. Pharm. Sci., 66, 242-253 (1977).
6. Hinderling P. H., Garrett E. R., Wester R. C., J. Pharm. Sci., 66, 314-325 (1977).
7. Shimada K., Mizusawa S., Ohkubo T., Nambara T., Chem. Pharm. Bull., 32, 2301-2306 (1984).
8. Thong B., Soldin S. J., Lingwood C. A., Clin. Chem., 31, 1625-1631 (1985).
9. Fujii Y., Ikeda Y., Yamazaki M., Clin. Chem., 40, 172-173 (1994).
10. Fujii Y., Ikeda Y., Fujii M., Yamazaki M., Biol. Pharm. Bull., 17, 467-471 (1994).
11. Ikeda Y., Fujii Y., Biol. Pharm. Bull., 23, 906-910 (2000).
12. Higashi Y., Watanabe N., Sasaki T., Fujii Y., Biol. Pharm. Bull., 25, 1251-1257 (2002).
13. Haack E., Kaiser F., Spingler H., Naturwissenschaften, 44, 633-634 (1957).
14. Yamaoka N., Nakagawa T., Uno T., J. Pharmacokinet. Biopharm., 6, 547-558 (1978).
15. Dimson P. A., Analytiche. International (Current), 3, 4-5 (1984).
16. Alan H. B. W., Terrie G. G., Clin. Chem., 31, 298-302 (1985).
17. Rameis H., Woodcock B., Bonelli J., Waginger H., Int. J. Clin. Pharmacol. Ther. Toxicol., 22, 145-151 (1984).
18. Soldin S. J., Clin. Chem., 32, 5-12 (1986).
19. Datta P., Dasgupta A., Ther. Drug Monit., 20, 663-668 (1998).
20. Kobayashi Y., Suzuki M., Ohshiro N., Sunagawa T., Sasaki T., Tokuyama S., Yamamoto T., Yoshida T., J. Toxicol. Sci., 26, 141-150 (2001).
21. Huang L., Wring S. A., Woolley J. L., Brouwer K. R., Serabjit-Singh C., Polli J. W., Drug Metab. Dispos., 29, 754-760 (2001).